LJPC - La Jolla Pharmaceutical Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-158,264
-199,469
-114,803
-78,185
-41,912
Depreciation & amortization
3,978
4,405
1,268
730
347
Deferred income taxes
-
-
-
-
-
Stock based compensation
29,008
35,151
21,795
14,546
13,072
Change in working capital
-2,791
512
6,660
4,162
3,294
Accounts receivable
-1,521
-1,381
-
-
-
Inventory
-1,029
-2,020
-
-
-
Accounts Payable
-1,161
-2,912
4,832
3,600
1,776
Other working capital
-119,048
-154,708
-94,075
-60,890
-26,999
Other non-cash items
9,820
6,797
-
75
16
Net cash provided by operating activites
-118,148
-152,368
-84,881
-58,672
-25,183
Cash flows from investing activities
Investments in property, plant and equipment
-900
-2,340
-9,194
-2,218
-1,816
Acquisitions, net
-
-
-
-
-
Purchases of investments
-
-
-
-
-
Sales/Maturities of investments
-
-
-
-
-
Other investing activites
-
-
-
0
0
Net cash used for investing activites
-900
-2,340
-9,194
-2,218
-1,816
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
875
110,200
117,480
0
104,596
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
-909
0
0
Net cash used privided by (used for) financing activities
1,067
236,397
119,264
149
104,911
Net change in cash
-117,981
81,689
25,189
-60,741
77,912
Cash at beginning of period
242,336
91,824
65,726
126,467
48,555
Cash at end of period
124,355
173,513
90,915
65,726
126,467
Free Cash Flow
Operating Cash Flow
-118,148
-152,368
-84,881
-58,672
-25,183
Capital Expenditure
-900
-2,340
-9,194
-2,218
-1,816
Free Cash Flow
-119,048
-154,708
-94,075
-60,890
-26,999